Literature DB >> 25588926

Survivorship in untreated breast cancer patients.

Carlos M Galmarini1, Olivier Tredan, Felipe C Galmarini.   

Abstract

In any disease, the knowledge of the natural history of untreated cases provides a real background against which the real advantages of a new treatment itself are judged. Fortunately, in the present days, there are scant data on outcomes in patients with untreated breast cancer. In an attempt to provide this background against which the virtues of current curative and palliative treatments can be more accurately assessed, we have reviewed the literature regarding published untreated breast cancer series. Taking into consideration all the difficulties of analyzing reports written on the last half of the nineteenth century or on the first half of the twentieth century, in most reports, patients survived almost 3-4 years without any type of treatment. Worth mentioning, approximately 5-10 % of untreated patients lived longer than 10 years. Thus, the spectrum of clinical aggressiveness of untreated breast cancer varies between virulence and chronic disease. These facts should be taken into account when considering the value of current treatments for early-stage disease.

Entities:  

Mesh:

Year:  2015        PMID: 25588926     DOI: 10.1007/s12032-014-0466-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  54 in total

1.  Control of cancer mortality.

Authors:  N E McKINNON
Journal:  Lancet       Date:  1954-01-30       Impact factor: 79.321

2.  Discussion on carcinoma of breast.

Authors:  S CADE
Journal:  Br J Radiol       Date:  1948-12       Impact factor: 3.039

3.  Dormancy of mammary carcinoma after mastectomy.

Authors:  T G Karrison; D J Ferguson; P Meier
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

4.  Long-term survival of women with breast cancer.

Authors:  D Brinkley; J L Haybittle
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

Review 5.  Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?

Authors:  Michael Baum; Romano Demicheli; William Hrushesky; Michael Retsky
Journal:  Eur J Cancer       Date:  2005-01-18       Impact factor: 9.162

6.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

7.  A comparison of treated and untreated cases of cancer of the breast.

Authors:  A J PHILLIPS
Journal:  Br J Cancer       Date:  1959-03       Impact factor: 7.640

8.  Does surgery modify growth kinetics of breast cancer micrometastases?

Authors:  R Demicheli; P Valagussa; G Bonadonna
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

9.  Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.

Authors:  D A Yardley; D Tripathy; A M Brufsky; H S Rugo; P A Kaufman; M Mayer; J Magidson; B Yoo; C Quah; M Ulcickas Yood
Journal:  Br J Cancer       Date:  2014-04-17       Impact factor: 7.640

10.  Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.

Authors:  H R Ali; E Provenzano; S-J Dawson; F M Blows; B Liu; M Shah; H M Earl; C J Poole; L Hiller; J A Dunn; S J Bowden; C Twelves; J M S Bartlett; S M A Mahmoud; E Rakha; I O Ellis; S Liu; D Gao; T O Nielsen; P D P Pharoah; C Caldas
Journal:  Ann Oncol       Date:  2014-06-09       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.